Finally, to ensure that PAPP-A and PAPP-A2 levels were analyzed in the context of lung cancer and not another undiscovered cancer disease, we excluded control patients who had an incident cancer diagnosis at another site during the first 2 years of follow-up. This evidence concerns the gene PAPPA2 and lung cancer.